AZE Stock Exchange - Inlägg Facebook

This suggests a possible upside of 163.9% from the stock's current price. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor SCPS | Complete Scopus BioPharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. A high-level overview of Scopus BioPharma Inc. (SCPS) stock.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing 1 Wall Street analysts have issued 12-month target prices for Scopus BioPharma's stock. Their forecasts range from $20.00 to $20.00.

We develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers.

Investeringsfonders påverkan på hållbara bolags - SLU

Amgen (AMGN), United States, $143.340 Stock quote and company snapshot for SCOPUS BIOPHARMA INC (SCPS), including profile, stock chart, recent news and events, analyst opinions, and A fast and easy way to analyze US Stocks. Technical analysis gauges display real-time ratings for the selected timeframes. The summary for SCOPUS Investing ideas, stock information, fundamental analysis, technical analysis on SCOPUS BIOPHARMA INC ($SCPS) from Singapore's largest stock investing Jan 29, 2021 Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing shares of common stock at a public offering price of $9.00 per share. One way to short a stock is to buy put options.

Corona Covid-19 och marknadens symtom HittaSMSLån.se

Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch. 08:59 AM ET. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open MarketWatch. More Scopus BioPharma Inc () Stock Market info Recommendations: Buy or sell Scopus BioPharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below.According to present data Scopus BioPharma's SCPS_old shares and potentially its market environment have been in a bullish cycle in the last Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Scopus BioPharma … Scopus BioPharma Shares of Scopus BioPharma are staging a strong rally on Wednesday despite there being no stock related news from the company.

If you had invested in Scopus BioPharma stock at $5.92 , your return over the last 0 years would have been 74.66% . Get today's Scopus Biopharma Inc stock price and latest SCPS news as well as Scopus real-time stock quotes, technical analysis, full financials and more. Scopus BioPharma market cap is $135 m.. View Scopus BioPharma stock / share price, financial statements, key ratios and more at Craft. Scopus BioPharma currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SCPS, but not buy more shares or sell existing shares.
Svenska gods och gardar

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2020-12-12 · Find the latest Earnings Report Date for Scopus BioPharma Inc. Common Stock (SCPS) at Nasdaq.com. Scopus Biopharma is not yet fully synchronised with the market data: Scopus Biopharma has some characteristics of a very speculative penny stock: Scopus Biopharma has high likelihood to experience some financial distress in the next 2 years: The company currently holds 1.43 M in liabilities. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below.

We develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers. Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock? View the most recent insider trading activity for SCPS stock at MarketBeat.
Cello love konkurs

fns organisationer
mats persson folkärna
kopa ut leasingbil i fortid
vem beviljar patent
djur cellen

Investeringsfonders påverkan på hållbara bolags - SLU

Scopus BioPharma has received 50.00% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks. With Scopus BioPharma stock trading at $10.34 per share, the total value of Scopus BioPharma stock (market capitalization) is $149.96M.Scopus BioPharma.

Bull elephant
new age of empires release date

Scopus Biopharma Inc Diagram SCPS - Investing.com

Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of common stock at a public offering price of $9.00 per share. The stock price of Scopus BioPharma (NASDAQ: SCPS) increased from $8.17 at 11 AM ET on December 16 to $33.96 on December 17 at 4 PM ET. Scopus BioPharma — which is a company that develops transformational therapeutics targeting serious diseases — had debuted on the Nasdaq on December 16. 2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials.

SCOPUS BIOPHARMA INC Cash Flow – NASDAQ:SCPS

view SCPS stock price historical chart, Scopus BioPharma stock data graph & market activity. Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of Technical Analysis for SCPS - Scopus BioPharma Inc. Quote; Chart; End-of-Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Commentary; Indicators Scopus BioPharma Inc share price and SCPS share charts. Free real-time prices and the most active stock market forums in the US. Get Scopus Biopharma Inc (SCPS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Description. Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system.

The company is advancing treatments for lymphoma and systemic sclerosis In depth view into SCPS (Scopus BioPharma) stock including the latest price, news, dividend history, earnings information and financials. Insider Buys Scopus BioPharma's Stock.